TrialThe oncologist2026

Preventive effect of goshajinkigan on paclitaxel-induced peripheral neuropathy: an open-label, randomized phase II study (OLCSG2101).

Takaaki Tanaka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.